Cargando…
Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study
OBJECTIVES: Patients with hematological malignancies have a high risk of mortality from coronavirus disease 2019 (COVID-19). This study aimed to investigate the impact of COVID-19 on mortality rates in patients with various hematological malignancies and to determine risk factors associated with all...
Autores principales: | Acar, Ibrahim Halil, Guner, Sebnem Izmir, Ak, Muzeyyen Aslaner, Gocer, Mesut, Ozturk, Erman, Atalay, Figen, Sincan, Gulden, Yikilmaz, Aysun Senturk, Ekinci, Omer, Ince, Idris, Gulturk, Emine, Demir, Nazli, Dogan, Ali, Ipek, Yildiz, Guvenc, Birol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652004/ https://www.ncbi.nlm.nih.gov/pubmed/36425152 http://dx.doi.org/10.4084/MJHID.2022.074 |
Ejemplares similares
-
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data
por: Aslaner Ak, Müzeyyen, et al.
Publicado: (2023) -
The High Effect of Chemomobilization with High-Dose Etopside + Granulocyte-Colony Stimulating Factor in Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation: A Single Center Experience
por: Güner, Şebnem Izmir, et al.
Publicado: (2016) -
Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera
por: Yikilmaz, Aysun Şentürk, et al.
Publicado: (2020) -
VAD Chemotherapy versus Bortezomib Containing Regimens as Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience
por: Yıkılmaz, Aysun Şentürk, et al.
Publicado: (2020) -
The Use of Gemtuzumab Ozogamicin as Salvage Therapy in Patients with Acute Myeloid Leukemia: A Monocentric Real-World Experience
por: Açar, İbrahim Halil, et al.
Publicado: (2023)